We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+19.85%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$1.79B
AUM Growth
+$298M
Cap. Flow
+$42.8M
Cap. Flow %
2.4%
Top 10 Hldgs %
26.42%
Holding
464
New
21
Increased
130
Reduced
91
Closed
43

Top Buys

Rank Stock Value
1
AMRN
Amarin Corp
AMRN
+$33.9M
2
CELG
Celgene Corp
CELG
+$20.2M
3
BIIB icon
Biogen
BIIB
+$9.9M
4
GILD icon
Gilead Sciences
GILD
+$9.89M
5
BBWI icon
Bath & Body Works
BBWI
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 33.37%
2 Technology 20.44%
3 Consumer Discretionary 12.16%
4 Financials 8.69%
5 Communication Services 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
126
Mondelez International
MDLZ
$80.5B
$3.13M 0.18%
63,370
+49,040
+342% +$2.25M
ICE icon
127
Intercontinental Exchange
ICE
$88.4B
$3.12M 0.17%
41,734
+1,930
+5% +$145K
ERIE icon
128
Erie Indemnity
ERIE
$12.2B
$3.04M 0.17%
17,047
-28,000
-62% -$4.5M
BLK icon
129
Blackrock
BLK
$170B
$2.92M 0.16%
6,898
+795
+13% +$334K
LLY icon
130
Eli Lilly
LLY
$1.03T
$2.91M 0.16%
22,600
+150
+0.7% +$18.2K
GWPH
131
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.88M 0.16%
17,500
RY icon
132
Royal Bank of Canada
RY
$292B
$2.82M 0.16%
37,010
+1,290
+4% +$97.6K
XOM icon
133
ExxonMobil
XOM
$651B
$2.75M 0.15%
34,000
DD icon
134
DuPont de Nemours
DD
$18.7B
$2.69M 0.15%
20,119
+1,690
+9% +$235K
AVGO icon
135
Broadcom
AVGO
$1.85T
$2.68M 0.15%
89,550
+48,000
+116% +$1.3M
CTRA
136
DELISTED
Coterra Energy
CTRA
$2.67M 0.15%
102,100
+94,100
+1,176% +$2.36M
ECL icon
137
Ecolab
ECL
$78.6B
$2.64M 0.15%
14,990
+60
+0.4% +$9.74K
RSP icon
138
Invesco S&P 500 Equal Weight ETF
RSP
$97.2B
$2.62M 0.15%
25,100
BPMC
139
DELISTED
Blueprint Medicines
BPMC
$2.6M 0.15%
34,400
IQV icon
140
IQVIA
IQV
$39.1B
$2.58M 0.14%
18,170
+170
+0.9% +$22.7K
TECH icon
141
Bio-Techne
TECH
$11.2B
$2.57M 0.14%
52,200
SEDG icon
142
SolarEdge
SEDG
$2.54B
$2.53M 0.14%
67,000
EMR icon
143
Emerson Electric
EMR
$83.3B
$2.52M 0.14%
36,750
+200
+0.5% +$13.2K
ARRY
144
DELISTED
Array Biopharma Inc
ARRY
$2.49M 0.14%
105,000
-14,200
-12% -$296K
BMY icon
145
Bristol-Myers Squibb
BMY
$132B
$2.46M 0.14%
51,650
-513,720
-91% -$25.6M
VMW
146
DELISTED
VMware, Inc
VMW
$2.46M 0.14%
13,840
+80
+0.6% +$13K
HP icon
147
Helmerich & Payne
HP
$3.37B
$2.44M 0.14%
43,940
CVX icon
148
Chevron
CVX
$383B
$2.39M 0.13%
19,450
-2,800
-13% -$331K
EEM icon
149
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$2.39M 0.13%
55,600
-4,200
-7% -$177K
AMP icon
150
Ameriprise Financial
AMP
$48.1B
$2.37M 0.13%
18,700

Similar funds

Erste Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Erste Asset Management held 464 positions worth $1.79B, up 20% from $1.49B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Erste Asset Management's Q1 2019 filing shows 21 new, 130 increased, 91 reduced and 43 closed positions. Its largest new stake was Ionis Pharmaceuticals: 48,000 shares worth $3.83M. The largest sale was Bristol-Myers Squibb, an estimated $25.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Erste Asset Management's largest Q1 2019 buy was Ionis Pharmaceuticals: 48,000 shares worth $3.83M.
  • Erste Asset Management added most to Amarin Corp in Q1 2019, an estimated $33.9M increase.
  • Erste Asset Management's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $25.6M.
  • Erste Asset Management fully exited Charles Schwab in Q1 2019, selling an estimated $4.42M.
  • Erste Asset Management's ten largest holdings make up 26% of its $1.79B portfolio in Q1 2019.
  • Erste Asset Management opened 21 new positions and closed 43 in Q1 2019.
  • Erste Asset Management's portfolio value rose 20% quarter-over-quarter to $1.79B.

Based on Erste Asset Management's 13F filing for Q1 2019, filed 22 Nov 2024.